Medicine – Hypertensive Retinopathy

Hypertensive retinopathy refers to retinal vascular changes caused by systemic arterial hypertension. Persistent high blood pressure damages the retinal arterioles, leading first to vasoconstriction and vessel-wall thickening, and in more severe disease to retinal ischaemia, haemorrhage, exudation, and optic-disc swelling.

The traditional grading system runs from Grade 1 to Grade 4, with increasing severity of retinal damage.

1. Grade 1 Hypertensive Retinopathy

Grade 1 disease represents relatively early vascular change.

The main abnormality is generalised arteriolar narrowing, reflecting vasoconstriction and early vessel-wall thickening.

The retinal arterioles may also show an increased light reflex, giving the vessel a brighter appearance.

2. Silver Wiring

Your note places silver wiring in Grade 1, but this is better thought of as a sign of more advanced arteriolar sclerosis.

As the arteriolar wall thickens, the normal blood-column reflex becomes increasingly prominent.

This progression is traditionally described as:

Copper wiring → silver wiring.

Copper wiring reflects moderate thickening and increased arteriolar light reflex.

Silver wiring reflects more severe sclerosis, where the vessel wall becomes so opaque that the blood column is difficult to see.

Therefore, silver wiring is a useful hypertensive/arteriosclerotic retinal sign, but it is not necessarily confined strictly to Grade 1.

3. Grade 2 Hypertensive Retinopathy

Grade 2 includes more obvious arteriolar changes, particularly arteriovenous crossing abnormalities.

The classic feature is AV nipping, also called AV nicking.

4. Arteriovenous Nipping

At points where a retinal arteriole crosses over a retinal vein, both vessels share a common adventitial sheath.

With chronic hypertension, the arteriole becomes thickened and rigid.

This compresses the underlying vein at the crossing point, producing AV nicking or nipping.

Therefore:

Thickened arteriole → compression of retinal vein at crossing → AV nipping.

5. Focal Arteriolar Attenuation

Grade 2 disease may also show focal narrowing of retinal arterioles.

This reflects localized vasoconstriction and structural arteriolar damage.

Generalised narrowing plus focal attenuation indicates more established hypertensive vascular disease than Grade 1.

6. Grade 3 Hypertensive Retinopathy

Grade 3 represents more severe retinal vascular injury and is associated with breakdown of the blood-retinal barrier and retinal ischaemia.

The important features are:

Retinal haemorrhages.

Hard exudates.

Cotton-wool spots.

These findings indicate significantly more severe hypertension and target-organ damage.

7. Retinal Haemorrhages

Retinal vascular damage can cause leakage of blood into the retina.

In hypertensive retinopathy, haemorrhages are commonly flame-shaped because blood tracks along the retinal nerve fibre layer.

Other patterns can occur depending on the depth of retinal involvement.

8. Hard Exudates

Hard exudates are yellow-white lipid deposits in the retina.

They result from leakage of plasma lipids and proteins through damaged retinal vessels.

They may accumulate around the macula in a radial pattern, producing a macular star in severe disease.

9. Cotton-Wool Spots

Cotton-wool spots are fluffy white retinal lesions caused by focal ischaemia of the retinal nerve fibre layer.

They represent interruption of axoplasmic transport following occlusion of small retinal arterioles.

Therefore:

Cotton-wool spots = retinal microinfarcts.

They are not specific to hypertension and may also occur in conditions such as diabetes, retinal vascular disease, HIV, and severe anaemia.

10. Grade 4 Hypertensive Retinopathy

Grade 4 represents the most severe form in the traditional classification.

It consists of the Grade 3 changes plus optic-disc swelling.

Historically this has often been described as papilloedema.

11. Optic-Disc Swelling in Severe Hypertension

In severe hypertensive emergency, the optic nerve head may become swollen as part of hypertensive optic neuropathy.

Older classifications call this “papilloedema,” but strictly speaking, papilloedema means optic-disc swelling caused by raised intracranial pressure.

Therefore, in modern terminology it is more accurate to say:

Grade 4 hypertensive retinopathy → severe retinopathy + optic-disc oedema.

If raised intracranial pressure is actually present, then the term papilloedema is appropriate.

12. Clinical Significance of Grade 4 Disease

Grade 4 hypertensive retinopathy usually indicates severe hypertension with acute target-organ injury.

This may occur in the context of a hypertensive emergency and requires urgent systemic assessment and blood-pressure management.

Associated complications may include encephalopathy, renal injury, cardiac failure, or other vascular damage.

13. Pathophysiological Progression

The progression can be remembered as:

Hypertension → arteriolar narrowing → vessel-wall sclerosis → AV crossing changes → retinal ischaemia/leakage → haemorrhages and exudates → optic-disc swelling in severe disease.

14. Hypertensive Retinopathy – Note Form

Grade 1: mild/generalised retinal arteriolar narrowing and increased arteriolar light reflex.

Copper/silver wiring: due to progressive arteriolar wall thickening; silver wiring represents more advanced sclerosis.

Grade 2: Grade 1 changes plus more obvious arteriolar damage, especially AV nicking/nipping and focal narrowing.

Grade 3: Grade 2 changes plus retinal haemorrhages, hard exudates and cotton-wool spots.

Grade 4: Grade 3 changes plus optic-disc swelling.

15. Quick Interpretation

Arteriolar narrowing → early hypertension.

AV nipping → chronic arteriolar sclerosis.

Haemorrhages + exudates + cotton-wool spots → severe hypertensive retinal injury.

Optic-disc swelling → very severe disease / hypertensive emergency.

Key Clinical Pattern

Remember the traditional sequence as:

Grade 1 → narrowing.

Grade 2 → AV nipping.

Grade 3 → haemorrhages + hard exudates + cotton-wool spots.

Grade 4 → optic-disc swelling.

A useful visual progression is:

Narrow vessels → crossing changes → retinal leakage/ischaemia → optic-disc oedema.

Infectious Disease and Microbiology – Enterococcus Species

Overview

Enterococcus species are Gram-positive cocci that normally colonize the human gastrointestinal tract but are important causes of healthcare-associated and opportunistic infections. The most clinically important species are Enterococcus faecalis and Enterococcus faecium.

Major infections include urinary tract infection, bacteremia, endocarditis, intra-abdominal and pelvic infection, neonatal infection, meningitis, and skin and soft-tissue infection.

Important Species

Clinically recognized species include:

• Enterococcus faecalis

• Enterococcus faecium

• Enterococcus avium

• Enterococcus casseliflavus

• Enterococcus durans

• Enterococcus gallinarum

• Enterococcus hirae

• Other Enterococcus species

Among these, E. faecalis and E. faecium account for most clinically important infections.

Microbiologic Characteristics

Enterococcus species are:

• Gram-positive cocci

• Facultatively anaerobic organisms

• Normal inhabitants of the gastrointestinal tract

• Opportunistic pathogens

• Notable for substantial intrinsic and acquired antimicrobial resistance

They were historically classified among the group D streptococci.

Colonization and Incubation

A conventional incubation period is difficult to define.

Infection commonly develops after a prolonged period of intestinal colonization, particularly in hospitalized or medically complex patients.

The sequence is often:

Intestinal colonization → disruption of host barriers or medical intervention → invasion → clinical infection

Epidemiology

Enterococcus species have become increasingly important causes of healthcare-associated infection.

They are prominent causes of hospital-acquired bacteremia, urinary tract infection, and infections involving indwelling medical devices.

Risk Factors

Important risk factors for invasive enterococcal infection include:

• Prolonged hospitalization

• Broad-spectrum antibiotic exposure

• Urinary or vascular catheters

• Recent surgery

• Intra-abdominal disease

• Immunosuppression

• Severe underlying illness

Bacteremia

Enterococcus species are important causes of bloodstream infection.

Bacteremia may be either:

• Monomicrobial

• Polymicrobial, particularly when arising from gastrointestinal or intra-abdominal sources

Potential sources include urinary infection, intra-abdominal infection, vascular catheters, and endocarditis.

Urinary Tract Infection

Enterococci are important causes of urinary tract infection, especially in hospitalized patients.

Risk is increased by:

• Indwelling urinary catheters

• Urinary instrumentation

• Structural urinary tract disease

• Prolonged hospitalization

Clinical disease ranges from cystitis to complicated UTI and urosepsis.

Infective Endocarditis

Enterococci can cause acute or subacute infective endocarditis.

E. faecalis is particularly important in this setting.

Patients may develop:

• Persistent bacteremia

• Fever

• Cardiac murmur

• Valvular vegetations

• Embolic or immunologic complications

Enterococcal endocarditis can be difficult to eradicate and generally requires prolonged antimicrobial therapy.

Intra-Abdominal and Pelvic Infection

Because enterococci normally colonize the gastrointestinal tract, they may participate in:

• Intra-abdominal abscesses

• Peritonitis

• Biliary infection

• Pelvic infections

• Postoperative abdominal infections

These infections are frequently polymicrobial.

Neonatal Infection

Enterococci can occasionally cause serious infections in neonates, particularly in hospitalized or premature infants.

Manifestations may include:

• Sepsis

• Bacteremia

• Meningitis

Meningitis

Enterococcal meningitis is uncommon but may occur in:

• Neonates

• Neurosurgical patients

• Immunocompromised individuals

• Patients with invasive enterococcal infection

Pneumonia

Enterococcus may occasionally be isolated in patients with pulmonary disease.

However, true enterococcal pneumonia is uncommon, and isolation from respiratory specimens should be interpreted carefully because colonization can occur.

Skin and Soft-Tissue Infection

Enterococci may participate in skin, soft-tissue, and wound infections, particularly in hospitalized patients.

These infections are frequently polymicrobial and may occur in surgical wounds or chronic ulcers.

Diagnosis

Diagnosis is established by culture of the pathogen from the appropriate clinical specimen.

Examples include:

• Blood cultures

• Urine culture

• Wound or abscess cultures

• Cerebrospinal fluid culture

Because antimicrobial resistance is common, susceptibility testing is essential for clinically significant infection.

Enterococcus faecalis Treatment

The source lists the following agents for susceptible E. faecalis:

• Amoxicillin

• Ampicillin

• Penicillin G

Ampicillin is commonly active against susceptible E. faecalis isolates.

Serious Infection and Endocarditis

The source describes treatment of serious infection or endocarditis using a cell-wall-active β-lactam combined with gentamicin, provided the organism does not demonstrate high-level aminoglycoside resistance.

The purpose of combination therapy is to achieve synergistic bactericidal activity.

Ampicillin + Gentamicin Synergy

The traditional principle is:

Ampicillin or penicillin damages the bacterial cell wall

• ●

Gentamicin enters the organism more effectively

→ Synergistic killing

However, high-level aminoglycoside resistance eliminates this synergistic effect.

Endocarditis Duration

Enterococcal endocarditis generally requires prolonged therapy.

The source describes:

Approximately 6 weeks of antimicrobial treatment

The exact regimen and duration depend on the valve involved, susceptibility pattern, prior therapy, and clinical circumstances.

Enterococcus faecium

E. faecium is particularly important because it is generally more antimicrobial-resistant than E. faecalis.

The source describes treatment with:

Vancomycin or teicoplanin, potentially combined with gentamicin when appropriate susceptibility is demonstrated.

However, resistant E. faecium strains are a major modern clinical problem.

Vancomycin-Resistant Enterococcus

A major high-yield concept is vancomycin-resistant Enterococcus (VRE).

VRE occurs particularly among E. faecium strains and is an important cause of healthcare-associated infection.

Resistance can substantially limit therapeutic options.

Important Intrinsic Vancomycin Resistance

E. gallinarum and E. casseliflavus have characteristic intrinsic low-level vancomycin resistance, associated with the VanC phenotype.

This distinguishes them from the acquired high-level vancomycin resistance encountered in many clinically important E. faecium isolates.

Additional Treatment Options

The source also lists:

• Imipenem

• Vancomycin

• Teicoplanin

• Amoxicillin–clavulanate

• Ampicillin–sulbactam

• Piperacillin–tazobactam

Actual therapy should be selected according to species identification, infection site, severity, and susceptibility testing.

Cystitis

For uncomplicated lower urinary infection, the source lists agents such as:

• Nitrofurantoin

• Ciprofloxacin

• Trimethoprim–sulfamethoxazole

However, susceptibility varies substantially, so urinary isolates should be interpreted according to the individual organism and susceptibility profile.

Important Resistance Characteristics

Enterococci are notable for resistance to many commonly used antimicrobial agents.

Important concepts include:

Intrinsic resistance to cephalosporins

Reduced susceptibility to many β-lactams

Possible high-level aminoglycoside resistance

Vancomycin resistance, especially in E. faecium

This combination of resistance mechanisms makes enterococci particularly important hospital pathogens.

E. faecalis vs. E. faecium

Enterococcus faecalis

→ More common in many clinical infections

→ Often more susceptible to ampicillin

→ Important cause of endocarditis and UTI

Enterococcus faecium

→ Generally more drug resistant

→ Frequently ampicillin resistant

→ Strongly associated with VRE

→ Particularly important in healthcare-associated infection

High-Yield Clinical Pattern

Hospitalized patient

• ●

Prolonged antibiotic exposure or indwelling catheter

• ●

UTI, bacteremia, or endocarditis

• ●

Gram-positive cocci with substantial antimicrobial resistance

→ Think Enterococcus

Endocarditis High-Yield Pattern

Persistent enterococcal bacteremia

• ●

Valvular vegetation/endocarditis

• ●

Need for prolonged therapy and bactericidal combination strategy when appropriate

→ Think Enterococcus faecalis

Exam Essentials

Genus: Enterococcus

Type: Gram-positive cocci

Normal habitat: Gastrointestinal tract

Major species: E. faecalis and E. faecium

Major infections: UTI, bacteremia, endocarditis, intra-abdominal and pelvic infection

Healthcare association: Strong

Diagnosis: Culture + susceptibility testing

E. faecalis: Often ampicillin susceptible

E. faecium: Generally more resistant

Important resistant phenotype: VRE, especially E. faecium

Aminoglycoside issue: High-level resistance eliminates synergistic killing

Endocarditis: Usually requires prolonged treatment

E. gallinarum/E. casseliflavus: Intrinsic VanC-mediated low-level vancomycin resistance

Cephalosporins: Enterococci are intrinsically resistant

Key clinical pearl: The major distinction is E. faecalis = often ampicillin susceptible and a classic cause of endocarditis, whereas E. faecium = substantially more drug resistant and strongly associated with VRE; serious enterococcal infections require susceptibility-guided therapy because intrinsic and acquired resistance are central features of this genus.

Infectious Disease and Microbiology – Enterobius vermicularis

Overview

Enterobius vermicularis is an intestinal nematode that causes enterobiasis, also called pinworm infection or oxyuriasis. It occurs worldwide and is particularly common in children and in households where reinfection can occur repeatedly.

The most characteristic symptom is perianal itching, especially at night.

⸻

Microbiologic Characteristics

Enterobius vermicularis is an intestinal nematode helminth.

Adult worms live mainly in the colon. At night, gravid female worms migrate to the perianal skin and deposit eggs, producing the characteristic itching associated with infection.

⸻

Life Cycle and Incubation

The life cycle of E. vermicularis is approximately:

2–6 weeks

However, repeated reinfection is common and may be necessary before symptoms become prominent.

⸻

Epidemiology

Pinworm infection has a worldwide distribution.

Transmission is especially common in:

• Children

• Families and household contacts

• Schools and daycare settings

• Crowded living environments

Because the eggs spread easily, infection can recur even after successful treatment.

⸻

Transmission

Transmission occurs mainly through the fecal–oral route after ingestion of infective eggs.

Eggs may contaminate:

• Hands and fingernails

• Bedding

• Clothing

• Toys

• Household surfaces

Autoinfection can occur when a person scratches the perianal area and later transfers eggs from the fingers to the mouth.

⸻

Enterobiasis

The disease caused by E. vermicularis is known as:

Enterobiasis

or

Pinworm infection

or

Oxyuriasis

Many infections are mild or asymptomatic.

⸻

Perianal Pruritus

The classic symptom is:

Nocturnal perianal itching

This occurs because female worms migrate out of the anus at night and deposit eggs on the surrounding skin.

Patients may develop:

• Intense itching

• Restless sleep

• Irritability

• Excoriations from scratching

⸻

Reinfection

Repeated infection is common because the eggs are easily transmitted within households.

The cycle may occur as:

Perianal itching → scratching → eggs under fingernails → hand-to-mouth transfer → reinfection

This is why hygiene measures and treatment of close contacts may be important.

⸻

Diagnosis

Diagnosis may be made by:

• Macroscopic identification of worms

• Detection of characteristic eggs using an adhesive tape preparation

The adhesive tape method is the classic diagnostic test.

⸻

Adhesive Tape Test

The test is performed by applying clear adhesive tape to the perianal skin, preferably early in the morning before bathing or defecation.

The tape is then examined microscopically for characteristic eggs.

Repeated sampling on several mornings may improve diagnostic yield.

⸻

Stool Examination

Adult worms may occasionally be visible macroscopically in stool.

However, routine stool microscopy is often less sensitive because eggs are deposited primarily on the perianal skin rather than directly into the stool.

⸻

Treatment

The source recommends:

Pyrantel pamoate 11 mg/kg orally as a single dose

Maximum dose:

1 g

Treatment should be repeated after 2 weeks.

⸻

Why Repeat Treatment?

The second dose is important because initial therapy kills the worms but may not eliminate all eggs.

A repeat dose approximately 2 weeks later helps eradicate worms that hatch after the first treatment.

⸻

Additional Treatment

Alternative regimens include:

Mebendazole 100 mg orally every 12 hours for 3 days

or

Albendazole 400 mg orally as a single dose

As with pyrantel pamoate, repeat treatment is often used to reduce recurrence.

⸻

Household Treatment

Treatment of the entire household should be considered, especially when more than one family member is infected.

This strategy helps interrupt the cycle of repeated transmission and reinfection.

⸻

Prevention

Good personal hygiene is the major preventive measure.

Important practices include:

• Frequent handwashing

• Washing hands after toileting and before eating

• Keeping fingernails short

• Avoiding nail biting

• Avoiding scratching the perianal region

• Washing bedding and clothing

• Regular bathing

• Cleaning frequently touched household surfaces

⸻

High-Yield Clinical Pattern

Child with intense nocturnal perianal itching

Possible household spread

Eggs detected by adhesive tape test

→ Think Enterobius vermicularis

⸻

Exam Essentials

Organism: Enterobius vermicularis

Type: Intestinal nematode

Disease: Enterobiasis / pinworm / oxyuriasis

Distribution: Worldwide

Life cycle: Approximately 2–6 weeks

Transmission: Fecal–oral ingestion of eggs

Classic symptom: Nocturnal perianal pruritus

Classic diagnostic test: Adhesive tape test

First-line treatment in source: Pyrantel pamoate

Important treatment principle: Repeat dose after 2 weeks

Alternatives: Mebendazole or albendazole

Household management: Consider treating close family members

Prevention: Good personal hygiene

⸻

Key clinical pearl: The classic association is child + nighttime perianal itching + positive adhesive tape test = Enterobius vermicularis, and treatment should usually be repeated after 2 weeks because reinfection is common.

Infectious Disease and Microbiology – Enterobacter Species

Overview

Enterobacter species are aerobic Gram-negative bacilli belonging to the Enterobacterales. They normally colonize the gastrointestinal tract but are important opportunistic and healthcare-associated pathogens.

Major infections include urinary tract infection, pneumonia, catheter-associated bacteremia, surgical-site infection, and neonatal meningitis.

Important Species

Species traditionally included in this group include:

• Enterobacter cloacae

• Enterobacter aerogenes

• Enterobacter sakazakii

• Enterobacter tayorae

• Other Enterobacter species

Some older names in this list have subsequently undergone taxonomic reclassification, but they may still appear in older microbiology references.

Microbiologic Characteristics

Enterobacter species are:

• Gram-negative bacilli

• Aerobic/facultatively anaerobic organisms

• Members of the Enterobacterales

• Common colonizers of the gastrointestinal tract

Their ability to acquire and express multiple mechanisms of antimicrobial resistance makes them important hospital pathogens.

Incubation Period

The incubation period is:

Unknown or not clearly defined

Because many infections arise from the patient’s own colonizing flora, a conventional exposure-to-disease incubation period is often difficult to establish.

Epidemiology

Enterobacter species may form part of the normal enteric flora.

Many infections are endogenous, meaning that the infecting strain originates from organisms that have already colonized the patient’s gastrointestinal tract.

Nosocomial Transmission

Enterobacter species are particularly important causes of healthcare-associated infections.

Hospital outbreaks have demonstrated that transmission may also occur through:

• Person-to-person spread

• Contaminated medical equipment or materials

• Common contaminated sources

• Contaminated intravenous solutions

Thus, infection is not always derived exclusively from the patient’s own intestinal flora.

Risk Factors

Infection is especially associated with patients who are:

• Hospitalized

• Critically ill

• Immunocompromised

• Receiving broad-spectrum antibiotics

• Using urinary or vascular catheters

• Mechanically ventilated

• Recently undergoing surgery

Urinary Tract Infection

Enterobacter species can cause healthcare-associated urinary tract infections, particularly in patients with urinary instrumentation or indwelling catheters.

Manifestations range from cystitis to complicated urinary infection and urosepsis.

Pulmonary Infection

These organisms can cause hospital-acquired pneumonia, particularly in critically ill or mechanically ventilated patients.

Pulmonary infection may progress to bacteremia and sepsis in severe cases.

Catheter-Associated Bacteremia

Enterobacter species are important causes of catheter-associated bloodstream infection.

An intravascular catheter may become colonized and serve as a persistent source of bacteremia.

Management may therefore require both appropriate antimicrobial therapy and evaluation for catheter removal.

Contaminated Intravenous Infusions

Hospital outbreaks have occasionally resulted from contaminated intravenous solutions or infusions.

This can expose multiple patients to the same organism and produce clusters of bloodstream infections.

Surgical Wound Infection

Enterobacter species may infect surgical wounds, particularly in hospitalized patients with prolonged healthcare exposure or prior antimicrobial treatment.

Such infections may be polymicrobial.

Neonatal Meningitis

Some organisms historically classified within this group have been associated with neonatal meningitis.

A particularly important organism in older terminology is Enterobacter sakazakii, now classified as Cronobacter sakazakii.

Cronobacter is especially associated with severe infections in neonates, including meningitis and sepsis.

Diagnosis

Diagnosis is established by culture of the pathogen from an appropriate clinical specimen.

Depending on the infection, specimens may include:

• Blood

• Urine

• Respiratory secretions

• Cerebrospinal fluid

• Surgical wound material

• Catheter-associated specimens

Antimicrobial susceptibility testing is especially important because resistance patterns can be complex.

Antimicrobial Resistance

A major clinical feature of several Enterobacter species, particularly the Enterobacter cloacae complex, is the potential for clinically significant AmpC β-lactamase production.

AmpC can confer resistance to multiple β-lactam antibiotics and may complicate treatment.

Resistance may emerge during therapy with certain cephalosporins even when the initial laboratory isolate appears susceptible.

Treatment

The source lists several treatment options, including:

• Carbapenems, such as imipenem or meropenem

• Piperacillin–tazobactam

• Fluoroquinolones

However, because antimicrobial resistance varies considerably, treatment of serious Enterobacter infection should be based on the species, infection site, severity, and susceptibility results.

Additional Treatment Options

The source also lists:

• Third-generation cephalosporins

• Aztreonam

• Aminoglycosides

However, the possibility of AmpC-mediated resistance is particularly important when considering some β-lactams for serious Enterobacter infections.

Therefore, older treatment lists should not be interpreted as universally appropriate empiric choices.

Source Control

Management of invasive infection may require source control in addition to antibiotics.

Examples include:

• Removal of an infected vascular catheter

• Drainage of an abscess

• Management of an infected surgical site

• Removal or replacement of contaminated devices when appropriate

High-Yield Clinical Pattern

Hospitalized or critically ill patient

• ●

Urinary catheter, central line, mechanical ventilation, or recent surgery

• ●

Gram-negative bacillus causing UTI, pneumonia, or bacteremia

• ●

Potential AmpC β-lactamase-mediated resistance

→ Think Enterobacter species

Important Taxonomy Pearl

Older microbiology references may use:

Enterobacter aerogenes → now Klebsiella aerogenes

Enterobacter sakazakii → now Cronobacter sakazakii

Recognizing these older names can be useful when reviewing historical infectious-disease literature.

Exam Essentials

Genus: Enterobacter

Type: Gram-negative bacillus

Normal habitat: Gastrointestinal flora

Major setting: Nosocomial/healthcare-associated infection

Transmission: Endogenous flora, person-to-person spread, or contaminated common sources

Major infections: UTI, pneumonia, bacteremia, surgical-site infection

Important device association: Intravascular and urinary catheters

Diagnosis: Culture + antimicrobial susceptibility testing

Important resistance mechanism: AmpC β-lactamase in clinically important species such as the E. cloacae complex

Treatment: Susceptibility-guided antimicrobial therapy; serious resistant infections may require agents such as carbapenems

Older name: E. aerogenes → Klebsiella aerogenes

Older name: E. sakazakii → Cronobacter sakazakii

Key clinical pearl: Enterobacter species are important hospital-acquired Gram-negative pathogens, and the major treatment consideration is their potential for AmpC-mediated β-lactam resistance, making culture and susceptibility testing essential when selecting therapy for serious infection.

Infectious Disease and Microbiology – Nonpathogenic Entamoeba Species

Overview

Several Entamoeba species may colonize the human gastrointestinal tract without producing clinically significant disease. Important examples include Entamoeba coli, Entamoeba hartmanni, and Entamoeba polecki.

These organisms are generally considered nonpathogenic intestinal protozoa and should not be confused with Entamoeba histolytica, which causes invasive amebiasis.

Important Species

The principal species in this group include:

• Entamoeba coli

• Entamoeba hartmanni

• Entamoeba polecki

These species are usually detected incidentally during parasitologic stool examination.

Microbiologic Characteristics

These Entamoeba species are protozoa that may inhabit the human intestinal tract.

The most important microbiologic distinction is:

Nonpathogenic Entamoeba species ≠ Entamoeba histolytica

E. histolytica is capable of tissue invasion and may cause intestinal and extraintestinal amebiasis, whereas E. coli, E. hartmanni, and E. polecki generally do not cause invasive disease.

Epidemiology

These nonpathogenic Entamoeba species have a worldwide distribution.

They may be detected in individuals from many geographic regions, particularly where exposure to fecally contaminated food or water occurs.

Clinical Significance

Most individuals carrying these organisms are asymptomatic.

Therefore, finding one of these Entamoeba species in a stool specimen usually represents intestinal colonization rather than active disease.

Possible Diarrhea

Although these organisms are generally considered nonpathogenic, some experts have suggested that they may rarely be associated with diarrhea.

However, when diarrhea occurs in a patient carrying one of these organisms, other causes should generally be investigated before attributing the symptoms to the Entamoeba species.

Distinction from Entamoeba histolytica

This distinction is particularly important for examinations and clinical interpretation.

E. histolytica

→ Pathogenic

→ Causes amebic colitis/dysentery

→ Can invade intestinal tissue

→ May disseminate to the liver and cause amebic liver abscess

E. coli, E. hartmanni,

and

E. polecki

→ Generally nonpathogenic

→ Usually asymptomatic

→ Typically represent intestinal colonization

→ Usually require no treatment

Entamoeba coli

Entamoeba coli is a nonpathogenic intestinal amoeba.

Importantly, Entamoeba coli is a protozoan and is completely different from Escherichia coli, the Gram-negative bacterium commonly abbreviated E. coli.

This distinction is a frequent source of confusion.

Diagnosis

Diagnosis is based on parasitologic examination of stool specimens.

Microscopic examination can demonstrate trophozoites or cyst forms and help distinguish nonpathogenic Entamoeba species from pathogenic E. histolytica.

Accurate identification is important because treatment requirements differ substantially.

Treatment

For uncomplicated colonization with these nonpathogenic Entamoeba species:

No treatment is usually required.

Their presence alone is not an indication for antiparasitic therapy.

Additional Treatment

The source describes treatment for the unusual patient who has:

An Entamoeba species detected

• ●

Persistent diarrhea

• ●

No other identifiable cause

Possible regimens described include:

Metronidazole 500 mg orally every 8 hours for 6 days

or

Tinidazole 1 g orally every 12 hours for 3 days

Because these organisms are generally regarded as nonpathogenic, treatment should not automatically follow a positive stool finding.

High-Yield Clinical Pattern

Protozoan detected in stool

• ●

Identified as E. coli, E. hartmanni, or E. polecki

• ●

No invasive intestinal disease

→ Think nonpathogenic Entamoeba colonization

Exam Essentials

Genus: Entamoeba

Species: E. coli, E. hartmanni, E. polecki

Type: Protozoa

Distribution: Worldwide

Usual pathogenicity: Nonpathogenic

Typical clinical course: Asymptomatic

Possible association: Rare diarrhea, although causality is uncertain

Diagnosis: Parasitologic stool examination

Routine treatment: None required

Critical distinction: Do not confuse with Entamoeba histolytica

E. histolytica: Causes invasive amebiasis

Key clinical pearl: Entamoeba coli, E. hartmanni, and E. polecki are generally nonpathogenic intestinal protozoa, so their detection in stool usually does not require treatment; the crucial clinical task is distinguishing them from pathogenic E. histolytica.

Infectious Disease and Microbiology – Endolimax nana

Overview

Endolimax nana is an intestinal protozoan with a worldwide distribution. It is generally regarded as a nonpathogenic commensal organism rather than a cause of gastrointestinal disease.

Its presence in stool usually reflects colonization rather than clinically significant infection.

Microbiologic Characteristics

Endolimax nana is a protozoan parasite that can inhabit the human intestinal tract.

Unlike pathogenic intestinal protozoa such as Entamoeba histolytica, E. nana is not considered an invasive or disease-producing organism.

Epidemiology

E. nana occurs worldwide.

It may be detected incidentally during stool examination, including in individuals who have no gastrointestinal symptoms.

Clinical Significance

Endolimax nana is generally considered nonpathogenic.

Therefore, detection of the organism does not usually explain symptoms such as diarrhea or abdominal pain.

If a symptomatic patient is found to have E. nana, other infectious or noninfectious causes of the symptoms should be considered.

Commensal Nature

The organism behaves primarily as a commensal intestinal protozoan.

This means it may live in the gastrointestinal tract without causing tissue invasion or clinically important disease.

Diagnosis

Diagnosis is based on parasitologic examination of concentrated stool specimens.

Characteristic protozoal forms may be identified microscopically.

Treatment

No treatment is required.

Because E. nana is considered nonpathogenic, antimicrobial or antiparasitic therapy is generally unnecessary.

High-Yield Clinical Pattern

Protozoan detected on stool examination

• ●

Patient has no symptoms or symptoms are better explained by another cause

• ●

Organism identified as Endolimax nana

→ Think nonpathogenic intestinal commensal

Exam Essentials

Organism: Endolimax nana

Type: Protozoan

Distribution: Worldwide

Pathogenicity: Nonpathogenic

Clinical role: Intestinal commensal

Diagnosis: Concentrated stool examination

Treatment: None required

Key clinical pearl: Finding Endolimax nana in stool usually represents nonpathogenic intestinal colonization, so treatment is not indicated and another cause should be sought if gastrointestinal symptoms are present.

Infectious Disease and Microbiology – Encephalitis Viruses of the Flaviviridae Family

Overview

Several members of the Flaviviridae family, particularly the genus Flavivirus, are arthropod-borne viruses (arboviruses) capable of causing encephalitis. These viruses are transmitted mainly by mosquitoes, although the broader group of arboviral encephalitides also includes tick-borne infections.

Important mosquito-borne flaviviral encephalitis viruses include Japanese encephalitis virus, Kunjin virus, Murray Valley encephalitis virus, St. Louis encephalitis virus, and Rocio virus.

Classification of Arboviral Encephalitis

Arthropod-borne viral encephalitides can broadly be considered according to their vectors, including:

• Mosquito-borne arboviral encephalitis

• Tick-borne arboviral encephalitis

Mosquito-borne encephalitis viruses belong to several different viral families or groups.

Major Groups of Mosquito-Borne Encephalitis Viruses

Important mosquito-borne encephalitis viruses include:

Alphaviruses

• Eastern equine encephalitis virus

• Western equine encephalitis virus

Bunyavirus-related viruses

• La Crosse virus

• California encephalitis virus

• Jamestown Canyon virus

• Snowshoe hare virus

Flaviviruses

• Japanese encephalitis virus

• Kunjin virus

• Murray Valley encephalitis virus

• St. Louis encephalitis virus

• Rocio virus

Microbiologic Characteristics

Flaviviruses associated with encephalitis are:

• Single-stranded RNA viruses

• Positive-sense RNA viruses

• Approximately spherical

• Enveloped

The presence of a lipid envelope distinguishes them from naked RNA viruses such as enteroviruses.

Incubation Period

The incubation period is generally approximately:

5–15 days

The exact interval varies according to the particular virus and host factors.

Epidemiology

Flaviviral encephalitis is relatively uncommon, although outbreaks can occur in endemic regions.

Transmission patterns depend heavily on:

• Geographic location

• Mosquito-vector distribution

• Climate and season

• Animal reservoirs

• Human exposure to mosquito habitats

Transmission

These encephalitis viruses are generally transmitted through the bite of an infected mosquito.

The virus is maintained in nature through transmission cycles involving mosquitoes and animal reservoirs.

Humans are often incidental hosts rather than essential components of the natural transmission cycle.

Clinical Infection

Flaviviruses can cause epidemic outbreaks of encephalitis.

Many infections may be asymptomatic or produce only a nonspecific febrile illness, while a smaller proportion progress to neurologic disease.

Encephalitis

When the central nervous system becomes involved, patients may develop:

• Fever

• Severe headache

• Altered mental status

• Confusion

• Behavioral changes

• Seizures

• Reduced level of consciousness

Severe disease may progress to coma or death.

Neurologic Manifestations

Depending on the specific flavivirus and severity of infection, neurologic manifestations may include:

• Encephalitis

• Meningoencephalitis

• Tremor

• Abnormal movements

• Weakness

• Seizures

• Altered consciousness

Survivors of severe encephalitis may occasionally have persistent neurologic deficits.

Japanese Encephalitis Virus

Japanese encephalitis virus (JEV) is one of the most important mosquito-borne causes of viral encephalitis in endemic areas of Asia.

Most infections are asymptomatic, but symptomatic neuroinvasive disease can be severe.

A major distinguishing feature is the availability of an effective vaccine.

St. Louis Encephalitis Virus

St. Louis encephalitis virus is another mosquito-borne flavivirus capable of causing outbreaks of encephalitis.

Neurologic disease tends to be more clinically significant in older adults.

Kunjin Virus

Kunjin virus is a flavivirus associated particularly with Australia.

It can produce febrile illness and, less commonly, encephalitis.

It is now generally regarded as a subtype/variant within the West Nile virus group.

Murray Valley Encephalitis Virus

Murray Valley encephalitis virus is a mosquito-borne flavivirus associated predominantly with Australia and surrounding regions.

Although infection is uncommon, neurologic disease can be severe.

Rocio Virus

Rocio virus is a mosquito-borne flavivirus historically associated with outbreaks of encephalitis in Brazil.

Human infection is uncommon but can result in significant neurologic disease.

Diagnosis

Traditional diagnostic methods include:

• Cell culture

• Serologic testing

Serology is particularly useful for demonstrating virus-specific antibodies.

Molecular Diagnosis

PCR can be used to detect viral genetic material in appropriate clinical specimens.

The choice of PCR, serology, and specimen type depends on the particular virus and the timing of specimen collection.

Treatment

Treatment is primarily supportive and symptomatic.

Management of severe encephalitis may include:

• Maintenance of airway and ventilation

• Fluid and electrolyte management

• Treatment of seizures

• Management of increased intracranial pressure when present

• Intensive supportive care for severe neurologic disease

Antiviral Therapy

For the flaviviral encephalitides described here, the source notes:

No specific antiviral treatment is available.

Management therefore focuses on supportive care and prevention of complications.

Prevention

The major preventive strategy is to avoid mosquito bites.

Measures include:

• Appropriate insect repellents

• Protective clothing

• Mosquito nets when appropriate

• Window and door screens

• Reduction of mosquito breeding sites

• Following local vector-control recommendations

Japanese Encephalitis Vaccination

Unlike most other mosquito-borne encephalitis viruses in this group, Japanese encephalitis can be prevented by vaccination.

Vaccination may be recommended for travelers whose itinerary, duration of travel, season, and activities create a meaningful risk of exposure in endemic areas.

The source particularly emphasizes vaccination for long-term travelers staying in rural endemic areas.

High-Yield Clinical Pattern

Recent mosquito exposure in an endemic region

• ●

Acute fever

• ●

Altered mental status ± seizures or other neurologic abnormalities

• ●

Serologic or molecular evidence of flavivirus infection

→ Consider flaviviral encephalitis

Japanese Encephalitis High-Yield Pattern

Travel or residence in endemic Asia

• ●

Mosquito exposure, particularly in rural areas

• ●

Acute encephalitis

→ Think Japanese encephalitis virus

Major prevention clue → Vaccine available

Exam Essentials

Group: Flavivirus

Family: Flaviviridae

Genome: Positive-sense single-stranded RNA

Envelope: Present

Shape: Approximately spherical

Vector: Primarily mosquitoes for the viruses discussed here

Incubation: Approximately 5–15 days

Major manifestation: Encephalitis/meningoencephalitis

Epidemiology: Usually uncommon, but outbreaks occur

Important viruses: Japanese encephalitis, Kunjin, Murray Valley encephalitis, St. Louis encephalitis, and Rocio viruses

Diagnosis: Serology, PCR, and historically viral culture

Treatment: Supportive

Routine specific antiviral therapy: None

General prevention: Avoid mosquito bites

Vaccine-preventable member: Japanese encephalitis virus

Key clinical pearl: Mosquito-borne flaviviruses are enveloped, positive-sense single-stranded RNA viruses that can cause epidemic encephalitis; Japanese encephalitis is especially important because an effective vaccine is available for people with appropriate exposure risk.

Infectious Disease and Microbiology – Emmonsia parva

Overview

Emmonsia parva is a filamentous fungus (mold) that is a rare cause of human infection. Although infection is uncommon worldwide, the organism has been associated with several forms of localized and invasive fungal disease, particularly in immunocompromised patients.

Reported manifestations include osteomyelitis, prosthetic valve endocarditis, respiratory and sinonasal infections, central nervous system extension, pneumonia, and disseminated disease.

Microbiologic Characteristics

Emmonsia parva is a:

• Filamentous fungus

• Mold

• Rare human fungal pathogen

Human disease caused by this organism is uncommon.

Epidemiology

E. parva has a worldwide distribution, but clinically significant human infection is rare.

Severe or disseminated disease is more likely to occur in individuals with impaired immune defenses.

Clinical Infections

A variety of uncommon infections have been attributed to E. parva, including:

• Osteomyelitis

• Prosthetic valve endocarditis

• Rhinitis

• Sinusitis

• CNS extension from sinus disease

• Pneumonia

• Disseminated infection

Osteomyelitis

Rare cases of E. parva osteomyelitis have been reported.

Fungal involvement of bone may produce a chronic infection requiring both prolonged antifungal therapy and, in selected cases, surgical management.

Prosthetic Valve Endocarditis

E. parva has rarely been associated with prosthetic valve endocarditis.

Fungal prosthetic valve infections are potentially serious because eradication can be difficult with antifungal therapy alone.

Rhinitis and Sinusitis

The organism may produce rhinitis or sinusitis.

Although these infections are rare, invasive sinus disease can potentially spread beyond the sinonasal structures.

CNS Extension

A particularly serious complication is extension of sinus infection into the central nervous system.

This represents an invasive form of disease requiring aggressive management.

Pneumonia

E. parva may occasionally cause pulmonary infection or pneumonia.

Pulmonary disease is especially concerning in patients with significant immunosuppression.

Disseminated Infection

In immunocompromised patients, infection may spread beyond its original site and produce disseminated fungal disease.

Multiple organs may potentially become involved in severe invasive infection.

Diagnosis

Diagnosis is established through:

• Fungal culture

• Identification of the fungus in tissue biopsy specimens

Because infection is rare, demonstrating fungal elements within affected tissue can be particularly important in establishing the organism’s clinical significance.

Tissue Biopsy

Histopathologic examination of a tissue biopsy can demonstrate fungal structures within the lesion.

Culture of biopsy material can then assist with definitive identification of the pathogen.

Thus, diagnosis often depends on a combination of:

Compatible lesion + tissue evidence of fungus + positive culture

Treatment

The treatment described in the source is:

Intravenous amphotericin B

This is used particularly for serious or invasive infection.

Surgical Management

Surgical intervention can be an important component of management.

Removal or debridement of infected lesions may help control localized disease and reduce the fungal burden.

Surgery may be particularly relevant when infection involves:

• Bone

• Localized masses or lesions

• Invasive sinus disease

• Prosthetic material

High-Yield Clinical Pattern

Immunocompromised patient

• ●

Unusual invasive fungal infection

• ●

Pneumonia, sinusitis with CNS extension, osteomyelitis, or dissemination

• ●

Filamentous fungus identified in culture or tissue

→ Consider Emmonsia parva

Exam Essentials

Organism: Emmonsia parva

Type: Filamentous fungus (mold)

Distribution: Worldwide

Frequency: Rare human pathogen

Important risk group: Immunocompromised patients

Possible infections: Osteomyelitis, prosthetic valve endocarditis, rhinitis, sinusitis, CNS extension, pneumonia, and disseminated infection

Diagnosis: Culture + identification in tissue biopsy

Treatment described in source: IV amphotericin B

Additional management: Surgical removal/debridement of lesions

Key clinical pearl: Emmonsia parva is a rare filamentous fungal pathogen that can cause serious localized or disseminated disease, especially in immunocompromised patients; diagnosis relies on culture and tissue identification, while treatment traditionally involves amphotericin B plus surgical management when appropriate.

Infectious Disease and Microbiology – Eikenella corrodens

Overview

Eikenella corrodens is a microaerophilic Gram-negative bacillus that belongs to the HACEK group. It is part of the normal human oral flora but can become pathogenic when introduced into normally sterile tissues.

It is particularly associated with human bite wounds, infections in intravenous drug users, endocarditis, and polymicrobial pulmonary infections.

Microbiologic Characteristics

Eikenella corrodens is characterized as:

• Gram-negative bacillus

• Microaerophilic

• Member of the HACEK group

• Normal inhabitant of the human oral cavity

The HACEK organisms are notable for their association with infective endocarditis.

HACEK Group

The traditional HACEK group consists of:

H – Haemophilus species

A – Aggregatibacter species

C – Cardiobacterium hominis

E – Eikenella corrodens

K – Kingella species

These are Gram-negative organisms associated particularly with infections originating from the oral or upper respiratory flora and with endocarditis.

Epidemiology

E. corrodens occurs worldwide, although clinically significant infection is relatively uncommon.

Because it normally colonizes the mouth, many infections result from introduction of oral flora into deeper tissues.

Normal Oral Flora

An important concept is that E. corrodens is part of the normal oral microbiota.

This explains its strong association with:

• Human bite wounds

• Oral contamination of traumatic wounds

• Head and neck infections

• Some pulmonary infections

• Infective endocarditis

Human Bite-Wound Infection

E. corrodens is a classic pathogen associated with human bites.

Human bite wounds are typically polymicrobial, and E. corrodens may be introduced into the wound together with other organisms from the oral cavity.

Clenched-Fist Injury

A particularly high-yield presentation is the clenched-fist injury, sometimes called a “fight bite.”

This occurs when a person’s fist strikes another person’s teeth, producing a small wound over a metacarpophalangeal joint.

Oral organisms such as E. corrodens may then be inoculated into deeper tissues, potentially resulting in:

• Cellulitis

• Abscess

• Septic arthritis

• Tenosynovitis

• Osteomyelitis

Infection in Intravenous Drug Users

E. corrodens can cause skin and soft-tissue infections in intravenous drug users.

These infections may be polymicrobial, particularly when oral flora contaminate injection equipment or the injection site.

Internal Jugular Vein Thrombophlebitis

E. corrodens has also been associated with internal jugular vein thrombophlebitis.

This represents a potentially serious invasive infection involving thrombosis and inflammation of the internal jugular vein.

Endocarditis

Because E. corrodens belongs to the HACEK group, it is an important though uncommon cause of infective endocarditis.

Clinical manifestations may include:

• Persistent fever

• Constitutional symptoms

• New or changing cardiac murmur

• Embolic phenomena

• Other manifestations of valvular infection

Pulmonary Infection

E. corrodens may cause several pulmonary and pleural infections, including:

• Pneumonia

• Lung abscess

• Empyema

These infections are commonly polymicrobial, reflecting the organism’s origin in the oral flora.

Diagnosis

Diagnosis is established by culture of appropriate clinical specimens.

Depending on the syndrome, specimens may include:

• Blood cultures

• Wound cultures

• Abscess material

• Pleural fluid

• Other infected tissue or fluids

Treatment

The source lists the principal treatments as:

Penicillin G

or

Amoxicillin–clavulanate

For human bite wounds, amoxicillin–clavulanate provides useful broad coverage because these infections are frequently polymicrobial.

Additional Treatment Options

Other agents described as potential alternatives include:

• Doxycycline

• Second-generation cephalosporins

• Third-generation cephalosporins

The source also lists aminoglycosides among possible agents.

Treatment of serious infection should ultimately be guided by culture and antimicrobial susceptibility results.

Beta-Lactamase Production

Some strains of E. corrodens produce beta-lactamases.

This possibility should be considered when selecting antimicrobial therapy, particularly if susceptibility results are not yet available.

Important Antibiotic Resistance

A particularly important feature of E. corrodens is its resistance to several antibiotics that might otherwise be considered for skin, oral, or anaerobic infections.

It is characteristically resistant to:

• Metronidazole

• Clindamycin

• Oxacillin

• First-generation cephalosporins

Human Bite Wound – Antibiotic Warning

Because E. corrodens may be present in human bite wounds:

Clindamycin alone should not be relied upon for empiric treatment.

Similarly, first-generation cephalosporins such as cephalexin or cefazolin do not provide reliable Eikenella coverage.

This resistance pattern is a major exam point.

High-Yield Clinical Pattern

Human bite or clenched-fist injury

• ●

Polymicrobial wound infection

• ●

Gram-negative bacillus from normal oral flora

• ●

Resistance to clindamycin and first-generation cephalosporins

→ Think Eikenella corrodens

Another High-Yield Association

HACEK organism

• ●

Subacute infective endocarditis

• ●

Oral flora

→ Consider Eikenella corrodens

Exam Essentials

Organism: Eikenella corrodens

Type: Microaerophilic Gram-negative bacillus

Group: HACEK

Normal habitat: Human oral flora

Classic infection: Human bite wound / clenched-fist injury

Other infections: Skin infection in IV drug users, internal jugular thrombophlebitis, endocarditis, pneumonia, lung abscess, and empyema

Pulmonary infections: Often polymicrobial

Diagnosis: Culture

Treatment: Penicillin G or amoxicillin–clavulanate

Possible alternatives: Doxycycline or second-/third-generation cephalosporins

Beta-lactamase: Some strains produce it

Important resistance: Metronidazole, clindamycin, oxacillin, and first-generation cephalosporins

Key clinical pearl: The classic association is human bite or fight-bite wound + normal oral flora + HACEK Gram-negative bacillus resistant to clindamycin and first-generation cephalosporins = Eikenella corrodens.

Microbiologic Characteristics Eikenella corrodens is characterized as: • Gram-negative bacillus

• Microaerophilic

• Member of the HACEK group

• Normal inhabitant of the human oral cavity The HACEK organisms are notable for their association with infective endocarditis.

HACEK Group The traditional HACEK group consists of: H – Haemophilus species

A – Aggregatibacter species

C – Cardiobacterium hominis

E – Eikenella corrodens

K – Kingella species These are Gram-negative organisms associated particularly with infections originating from the oral or upper respiratory flora and with endocarditis.

Epidemiology E. corrodens occurs worldwide, although clinically significant infection is relatively uncommon. Because it normally colonizes the mouth, many infections result from introduction of oral flora into deeper tissues.

Normal Oral Flora An important concept is that E. corrodens is part of the normal oral microbiota. This explains its strong association with: • Human bite wounds

• Oral contamination of traumatic wounds

• Head and neck infections

• Some pulmonary infections

• Infective endocarditis

Human Bite-Wound Infection E. corrodens is a classic pathogen associated with human bites. Human bite wounds are typically polymicrobial, and E. corrodens may be introduced into the wound together with other organisms from the oral cavity.

Clenched-Fist Injury A particularly high-yield presentation is the clenched-fist injury, sometimes called a “fight bite.” This occurs when a person’s fist strikes another person’s teeth, producing a small wound over a metacarpophalangeal joint. Oral organisms such as E. corrodens may then be inoculated into deeper tissues, potentially resulting in: • Cellulitis

• Abscess

• Septic arthritis

• Tenosynovitis

• Osteomyelitis

Infection in Intravenous Drug Users E. corrodens can cause skin and soft-tissue infections in intravenous drug users. These infections may be polymicrobial, particularly when oral flora contaminate injection equipment or the injection site.

Internal Jugular Vein Thrombophlebitis E. corrodens has also been associated with internal jugular vein thrombophlebitis. This represents a potentially serious invasive infection involving thrombosis and inflammation of the internal jugular vein.

Endocarditis Because E. corrodens belongs to the HACEK group, it is an important though uncommon cause of infective endocarditis. Clinical manifestations may include: • Persistent fever

• Constitutional symptoms

• New or changing cardiac murmur

• Embolic phenomena

• Other manifestations of valvular infection

Pulmonary Infection E. corrodens may cause several pulmonary and pleural infections, including: • Pneumonia

• Lung abscess

• Empyema These infections are commonly polymicrobial, reflecting the organism’s origin in the oral flora.

Diagnosis Diagnosis is established by culture of appropriate clinical specimens. Depending on the syndrome, specimens may include: • Blood cultures

• Wound cultures

• Abscess material

• Pleural fluid

• Other infected tissue or fluids

Treatment The source lists the principal treatments as: Penicillin G or Amoxicillin–clavulanate For human bite wounds, amoxicillin–clavulanate provides useful broad coverage because these infections are frequently polymicrobial.

Additional Treatment Options Other agents described as potential alternatives include: • Doxycycline

• Second-generation cephalosporins

• Third-generation cephalosporins The source also lists aminoglycosides among possible agents. Treatment of serious infection should ultimately be guided by culture and antimicrobial susceptibility results.

Beta-Lactamase Production Some strains of E. corrodens produce beta-lactamases. This possibility should be considered when selecting antimicrobial therapy, particularly if susceptibility results are not yet available.

Important Antibiotic Resistance A particularly important feature of E. corrodens is its resistance to several antibiotics that might otherwise be considered for skin, oral, or anaerobic infections. It is characteristically resistant to: • Metronidazole

• Clindamycin

• Oxacillin

• First-generation cephalosporins

Human Bite Wound – Antibiotic Warning Because E. corrodens may be present in human bite wounds: Clindamycin alone should not be relied upon for empiric treatment. Similarly, first-generation cephalosporins such as cephalexin or cefazolin do not provide reliable Eikenella coverage. This resistance pattern is a major exam point.

High-Yield Clinical Pattern Human bite or clenched-fist injury  ●  Polymicrobial wound infection  ●  Gram-negative bacillus from normal oral flora  ●  Resistance to clindamycin and first-generation cephalosporins → Think Eikenella corrodens

Another High-Yield Association HACEK organism  ●  Subacute infective endocarditis  ●  Oral flora → Consider Eikenella corrodens

Exam Essentials Organism: Eikenella corrodens

Type: Microaerophilic Gram-negative bacillus

Group: HACEK

Normal habitat: Human oral flora

Classic infection: Human bite wound / clenched-fist injury

Other infections: Skin infection in IV drug users, internal jugular thrombophlebitis, endocarditis, pneumonia, lung abscess, and empyema

Pulmonary infections: Often polymicrobial

Diagnosis: Culture

Treatment: Penicillin G or amoxicillin–clavulanate

Possible alternatives: Doxycycline or second-/third-generation cephalosporins

Beta-lactamase: Some strains produce it

Important resistance: Metronidazole, clindamycin, oxacillin, and first-generation cephalosporins

Key clinical pearl: The classic association is human bite or fight-bite wound + normal oral flora + HACEK Gram-negative bacillus resistant to clindamycin and first-generation cephalosporins = Eikenella corrodens.

Infectious Disease and Microbiology – Edwardsiella tarda

Overview

Edwardsiella tarda is an aerobic, Gram-negative bacillus that is an uncommon cause of human infection. It is found worldwide and is associated with the intestinal flora of various animals, including snakes.

The major human infections are gastroenteritis and bacteremia.

Microbiologic Characteristics

Edwardsiella tarda is an:

• Aerobic Gram-negative bacillus

• Enteric bacterium

• Organism associated with the gastrointestinal tracts of various animals

It can be isolated using standard bacterial culture techniques.

Epidemiology

Human E. tarda infection is rare but occurs worldwide.

The organism may be part of the normal intestinal flora of various animals, particularly:

• Reptiles, including snakes

• Fish and other aquatic animals

• Other animal species

Human infection may therefore have an environmental or animal-associated source.

Transmission and Exposure

Exposure may occur through contact with colonized animals or contaminated aquatic environments and through consumption of contaminated food.

Because of its association with aquatic animals and reptiles, a history of fish, water, or reptile exposure may provide an important epidemiologic clue.

Clinical Infections

The two principal clinical manifestations described for E. tarda are:

1. Gastroenteritis

2. Bacteremia

Most infections remain gastrointestinal, but invasive bloodstream infection can occur and requires more aggressive management.

Gastroenteritis

E. tarda can cause an acute gastrointestinal illness characterized primarily by diarrhea and abdominal symptoms.

Possible manifestations include:

• Diarrhea

• Abdominal pain or cramping

• Nausea and vomiting

• Fever

The clinical presentation may resemble gastroenteritis caused by other enteric Gram-negative organisms.

Bacteremia

E. tarda can occasionally invade the bloodstream and produce bacteremia.

This represents a more serious form of infection and may be associated with systemic manifestations such as:

• Fever

• Chills

• Hypotension in severe disease

• Sepsis

Recognition of bloodstream infection is important because intravenous antimicrobial treatment is required.

Diagnosis

Diagnosis is established by bacterial culture.

Depending on the clinical syndrome, appropriate specimens include:

• Stool culture for gastroenteritis

• Blood cultures for suspected bacteremia

• Cultures from other infected sites when appropriate

Identification of the organism should be accompanied by antimicrobial susceptibility testing in serious infections.

Treatment

The primary antimicrobial treatment described in the source is a:

Fluoroquinolone

For patients with E. tarda bacteremia, the source specifically recommends intravenous treatment with a quinolone.

Additional Treatment Options

Other antimicrobial agents with potential activity include:

• Ampicillin

• Aminoglycosides

• Cephalosporins

For invasive infection, antimicrobial selection should be guided by the isolate’s susceptibility pattern and the clinical severity of disease.

High-Yield Clinical Pattern

Animal, reptile, fish, or aquatic exposure

• ●

Gastroenteritis

or

Bacteremia/sepsis

• ●

Aerobic Gram-negative bacillus isolated by culture

→ Consider Edwardsiella tarda

Exam Essentials

Organism: Edwardsiella tarda

Type: Aerobic Gram-negative bacillus

Distribution: Worldwide

Frequency: Rare human pathogen

Reservoir: Intestinal flora of animals, including snakes

Important exposures: Reptiles and aquatic environments/animals

Major infections: Gastroenteritis and bacteremia

Diagnosis: Culture

Primary treatment: Fluoroquinolone

Bacteremia: Intravenous antimicrobial therapy is required

Additional options: Ampicillin, aminoglycosides, or cephalosporins

Key clinical pearl: Think of Edwardsiella tarda when gastroenteritis or bacteremia occurs after aquatic-animal or reptile exposure; invasive bloodstream infection is the major serious manifestation and requires systemic antimicrobial therapy.